SCHRODER INVESTMENT MANAGEMENT GROUP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$69,150,475
-18.5%
771,941
-22.5%
0.10%
-15.6%
Q2 2023$84,817,149
+8.4%
996,208
+5.3%
0.12%
+5.2%
Q1 2023$78,250,386
+4.4%
945,624
-0.8%
0.12%
-2.5%
Q4 2022$74,952,113
+3.0%
952,983
-3.1%
0.12%
-0.8%
Q3 2022$72,771,000
+46.1%
982,997
+28.6%
0.12%
+57.9%
Q2 2022$49,805,000
+61.0%
764,111
+56.2%
0.08%
+85.4%
Q1 2022$30,936,000
+6.9%
489,337
-10.3%
0.04%
+7.9%
Q4 2021$28,950,000
-4.2%
545,821
+27.5%
0.04%
-17.4%
Q3 2021$30,215,000
-15.4%
428,032
-20.1%
0.05%
+2.2%
Q2 2021$35,715,000
+7.8%
535,934
+79.6%
0.04%
+4.7%
Q1 2021$33,121,000
-32.3%
298,360
-27.6%
0.04%
+26.5%
Q4 2020$48,948,000
+5811.6%
412,188
+4254.9%
0.03%
+3300.0%
Q1 2019$828,000
-95.4%
9,465
-94.7%
0.00%
-97.0%
Q4 2018$18,024,000
+1199.5%
180,155
+1388.0%
0.03%
+1550.0%
Q3 2018$1,387,000
+28.2%
12,1070.0%0.00%0.0%
Q2 2018$1,082,000
-29.1%
12,107
-42.0%
0.00%
-33.3%
Q1 2018$1,527,000
+26.0%
20,8690.0%0.00%
+50.0%
Q4 2017$1,212,000
-22.6%
20,869
-42.3%
0.00%
-33.3%
Q3 2017$1,565,000
-100.0%
36,194
-85.9%
0.00%
-66.7%
Q1 2014$8,385,407,000
-21.6%
257,300
+1.3%
0.01%
-30.8%
Q4 2013$10,701,020,000
-40.7%
254,000
-43.9%
0.01%
-70.5%
Q3 2013$18,053,676,000
-23.0%
452,700
-20.1%
0.04%
-29.0%
Q2 2013$23,437,180,000566,8000.06%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders